Ascites and encephalopathy in chronic liver disease

Indian Journal of Pediatrics

Volumn 69, Issue 2, 2002, Pages 169-173

  Hardikar, Winita ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Ascites; Children; Encephalopathy; Liver failure; Liver transplantation

Indexed keywords

AMOXICILLIN; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BRANCHED CHAIN AMINO ACID; BROMOCRIPTINE; CEFOTAXIME; DIURETIC AGENT; FLUMAZENIL; FUROSEMIDE; LACTULOSE; LEVODOPA; NEOMYCIN; NORFLOXACIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADOLESCENT; ASCITES; BACTERIAL PERITONITIS; CHILD; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DIURETIC THERAPY; DRUG MECHANISM; GYNECOMASTIA; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPERKALEMIA; HYPERURICEMIA; HYPOKALEMIA; INFANT; KIDNEY CALCIFICATION; KIDNEY TUBULE DISORDER; LIVER FAILURE; NEWBORN; OTOTOXICITY; PANCREATITIS; PARACENTESIS; PORTOSYSTEMIC ANASTOMOSIS; PROGNOSIS; RASH; SODIUM RESTRICTION;

EID: 0036121140     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02859379     Document Type: Conference Paper

References (22)

1. Morali GA, Snideramn KW, Deitel KM et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 11992; 16 : 249-250.
2. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites and spontaneous bacterial peritonitis. Gastroenterology 2001; 120 : 726-748.
3. Rossle M, Ochs A, Golberg V et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342 : 1701-1707.
4. Garcia-Tsao G. Treatment of refractory ascites: tips or taps? Hepatology 2001; 33 : 477-479.
5. Heyman MB, LaBerge JM. Role of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension in pediatric patients. J Ped Gastro Nutr 1999; 29 : 240-249.
6. Rimola A, Garcia-Tsao G, Navasa M, Piddock V, Planas R, Bernard B et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32 : 142-153.
7. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almale M. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12 : 716-724.
8. Jones EA. Pathogenesis of hepatic encephalopathy. Clinics in Liver Dis 2000; 4 : 467-485.
9. Albrecht J, Dolinska M. Glutamine as a pathogenic factor in hepatic encephalopathy. J Neuroscience Res 2001; 65 : 1-5.
10. Sand P., Kavvadias D, Feineis D et al. Naturally occurring benzodiazepines:current status of research and clinical implications. Eur Arch Psych Clin Neuroscience 2000; 250 : 194-202.
11. Watanabe A. Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 1998; 13 : 752-760.
12. Weber Fl Jr. Lactulose and combination therapy of hepatic encephalopathy: the role of intestinal microflora. Dig Dis 1996 ; 14 : 53-63.
13. Scevola D, Zarmelli A, Concia E et al. Non-absorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other? La Clinica Terapeutica 1989; 129 : 105-111.
14. Marchesini G, Bianchi G, Rossi B, Brizi M, Melchionda N. Nutritional treatment with branched-chain amino-acids in advanced liver cirrhosis. J Gastroenterol 2000; 35 : 7-12.
15. Charlton CPJ, Buchanan E, Holden CE et al. Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy. Arch Dis Child 1992; 67 : 603-607.
16. D' Amico G, Morabito A, Pagliaro L et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31 : 468-475.
17. Matalack J, Shaid D, Urback A et al. Choosing a pediatric recipient for orthotopic liver transplantation. J Pediatr 1987; 111 : 479-489.
18. Wayman KI, Cox KL, Esquivel CO Neuro-developmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pediatr 1997; 131 : 894-894.
19. Bhaduri RR, Mieli-Vergani G. Fulminant hepatic failure: Pediatric aspects. Semin Liver Dis 1996; 16 : 349-355.
20. Hartmann U, Groeneweg M, Quero JC et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastro 2000; 95 : 2029-2034.
21. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33 : 464-470.
22. rd edn. Philadelphia: W.B. Saunders, 1996; 12: 605-617.